Project Grant HT94252410611
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
This $992,377 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Colorado-Denver to investigate the mechanisms of IgG antibody-mediated neuronal cytotoxicity in multiple sclerosis. The 3-year research project aims to advance understanding of the immunological processes underlying neurological damage in multiple sclerosis patients. The University of Colorado-Denver, a major public...
The Defense Health Agency awarded a $320,000 Project Grant to the Regents of the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2025 to determine the mechanisms underlying remyelination by surviving oligodendrocytes. The research aims to advance understanding of how the central nervous system repairs myelin sheaths, with potential implications for treating multiple...
The Defense Health Agency awarded a $1,260,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, effective May 1, 2025 through April 30, 2029, will support research targeting EHMT1/2 to overcome therapy-resistant ovarian cancer. As a prominent public research university, the University of Colorado-Denver leverages its expertise across multiple...
This federal Project Grant award, valued at $911,151.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of PEG10 inhibitors to fight against amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The award was granted to The Regents of the University of Colorado, a prominent public research university based in Boulder, Colorado, for the project period from February 15, 2025 to February...
The federal Project Grant award of $2,271,024.00 was provided by the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, to the University of Colorado-Denver. The award, effective November 1, 2024, supports a four-year research project to improve understanding of next-generation immunotherapy responses in metastatic uveal melanoma. The University of Colorado-Denver, a major public research university with a strong focus on medical...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $577,680.00 to The Regents of the University of Colorado to conduct research aimed at "TARGETING EHMT1/2 TO OVERCOME THERAPY-RESISTANT OVARIAN CANCER". The research, to be performed at the University of Colorado in Boulder, CO, seeks to develop innovative medical solutions to transform healthcare for military service members, veterans, and the...
The U.S. Defense Health Agency has awarded a $499,998 Project Grant to the University of Colorado-Denver under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, is for developing a preservation method for vascularized composite allotransplantation (VCA) during static cold storage. This research aims to transform healthcare for military service members and the broader public by...
The University of Colorado was awarded a $1,586,723 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of microglia in sleep disturbances following a traumatic brain injury. Through this funding, the University of Colorado aims to transform military and public health by gaining medical insights on the...